New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...